Smart Nanoparticles for Drug Delivery: Boundaries and Opportunities.
暂无分享,去创建一个
[1] F. Schué,et al. Terminology for biorelated polymers and applications (IUPAC Recommendations 2012) , 2012 .
[2] Holger Grüll,et al. In vivo temperature controlled ultrasound-mediated intracellular delivery of cell-impermeable compounds. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[3] Darrell J Irvine,et al. Drug delivery: One nanoparticle, one kill. , 2011, Nature materials.
[4] Tonglei Li,et al. Biodistribution and bioimaging studies of hybrid paclitaxel nanocrystals: lessons learned of the EPR effect and image-guided drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[5] Alexander T Florence,et al. "Targeting" nanoparticles: the constraints of physical laws and physical barriers. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[6] Peter Wust,et al. Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study. , 2010, The Lancet. Oncology.
[7] David W Grainger,et al. Connecting drug delivery reality to smart materials design. , 2013, International journal of pharmaceutics.
[8] E. R. Cooper,et al. Nanoparticles: A personal experience for formulating poorly water soluble drugs. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[9] Ying Zhang,et al. Advanced materials and processing for drug delivery: the past and the future. , 2013, Advanced drug delivery reviews.
[10] R. Weinberg,et al. The Biology of Cancer , 2006 .
[11] Jouni Hirvonen,et al. Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods , 2010, The Journal of pharmacy and pharmacology.
[12] Kinam Park,et al. Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Förster resonance energy transfer imaging , 2008, Proceedings of the National Academy of Sciences.
[13] J. Kelm,et al. 3D cell culture systems modeling tumor growth determinants in cancer target discovery. , 2014, Advanced drug delivery reviews.
[14] M. Faraday. X. The Bakerian Lecture. —Experimental relations of gold (and other metals) to light , 1857, Philosophical Transactions of the Royal Society of London.
[15] Panos Macheras,et al. A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.
[16] Seiji Miura,et al. Mind the gap: a survey of how cancer drug carriers are susceptible to the gap between research and practice. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[17] David Needham,et al. Reverse engineering of the low temperature-sensitive liposome (LTSL) for treating cancer , 2013 .
[18] Efstathios Karathanasis,et al. Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[19] Kinam Park,et al. Introduction to biomaterials for cancer therapeutics , 2013 .
[20] R. Jain,et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[21] Lev Ruzer,et al. Unattached Fraction of Radon Progeny as an Experimental Tool in the Assessment of the Risk of Nanoparticles , 2012 .
[22] Kinam Park,et al. Targeted drug delivery to tumors: myths, reality and possibility. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[23] A. Bangham,et al. NEGATIVE STAINING OF PHOSPHOLIPIDS AND THEIR STRUCTURAL MODIFICATION BY SURFACE-ACTIVE AGENTS AS OBSERVED IN THE ELECTRON MICROSCOPE. , 1964, Journal of molecular biology.
[24] U. Nielsen,et al. Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models. , 2006, Cancer research.
[25] L. Zhang,et al. Nanoparticles in Medicine: Therapeutic Applications and Developments , 2008, Clinical pharmacology and therapeutics.
[26] Andhra Pradesh,et al. NANOPARTICLES AS DRUG DELIVERY SYSTEMS , 2012 .
[27] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[28] Katherine W Ferrara,et al. Accumulation, internalization and therapeutic efficacy of neuropilin-1-targeted liposomes. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[29] P. Cullis,et al. Liposomal drug delivery systems: from concept to clinical applications. , 2013, Advanced drug delivery reviews.
[30] S. Nie,et al. Therapeutic Nanoparticles for Drug Delivery in Cancer Types of Nanoparticles Used as Drug Delivery Systems , 2022 .
[31] Ali Khademhosseini,et al. Biocompatibility of engineered nanoparticles for drug delivery. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[32] D. Crommelin,et al. Towards more effective advanced drug delivery systems. , 2013, International journal of pharmaceutics.
[33] Kinam Park,et al. Analysis on the current status of targeted drug delivery to tumors. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[34] J. Kreuter,et al. In vitro studies of poly(methyl methacrylate) adjuvants. , 1976, Journal of pharmaceutical sciences.
[35] Rahul P Gangwal,et al. Oral delivery of anticancer drugs: challenges and opportunities. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[36] Harald Schubert,et al. Pharmacokinetics of temoporfin-loaded liposome formulations: correlation of liposome and temoporfin blood concentration. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[37] Xiabin Jing,et al. Photosensitive Pt(IV)-azide prodrug-loaded nanoparticles exhibit controlled drug release and enhanced efficacy in vivo. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[38] Matthias Wacker,et al. Nanocarriers for intravenous injection--the long hard road to the market. , 2013, International journal of pharmaceutics.
[39] L. Brannon-Peppas,et al. Nanoparticle and targeted systems for cancer therapy. , 2004, Advanced drug delivery reviews.
[40] Lei Gao,et al. Drug nanocrystals: In vivo performances. , 2012, Journal of controlled release : official journal of the Controlled Release Society.
[41] Jun Wang,et al. Rosiglitazone-loaded nanospheres for modulating macrophage-specific inflammation in obesity. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[42] Kinam Park,et al. Facing the truth about nanotechnology in drug delivery. , 2013, ACS nano.
[43] Henry C. Pitot,et al. The Biology of Cancer. Second Edition. By Robert A. Weinberg. New York: Garland Science (Taylor & Francis Group). $150.00 (paper). xx + 876 p.; ill.; A:1-A:6; G:1-G:30; I:1-I:28 (index). ISBN: 978-0-8153-4220-5. [A DVD-ROM accompanies the book.] 2014. , 2014 .
[44] Li Li,et al. A novel two-step mild hyperthermia for advanced liposomal chemotherapy. , 2014, Journal of controlled release : official journal of the Controlled Release Society.
[45] Y Li,et al. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[46] Holger Grüll,et al. Real-time imaging and kinetics measurements of focused ultrasound-induced extravasation in skeletal muscle using SPECT/CT. , 2013, Journal of controlled release : official journal of the Controlled Release Society.